Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
07:16pm, Thursday, 08'th Jan 2026
Astrazeneca (AZN) concluded the recent trading session at $94.01, signifying a -1.21% move from its prior day's close.
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
10:51am, Thursday, 08'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AstraZeneca names Rick Suarez head of US biopharmaceuticals unit
07:12am, Thursday, 08'th Jan 2026
AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's previously announced $50 billion research, development and manufac
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
07:00am, Thursday, 08'th Jan 2026
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. Suarez will lead the execution of the C
JNJ vs. AZN: Which Drug Stock Comes Out on Top for Investors?
12:55pm, Tuesday, 06'th Jan 2026
J&J's diversified pharma and MedTech strength stacks up against AstraZeneca's oncology-led growth as investors weigh stability versus faster expansion.
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?
10:45am, Tuesday, 06'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
JP Morgan expects solid AstraZeneca quarter and reassuring outlook
08:13am, Tuesday, 06'th Jan 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month, according to JP Morgan, which expects earnings to come in modestly ahe
JP Morgan expects solid AstraZeneca quarter and reassuring outlook
07:46am, Tuesday, 06'th Jan 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month, according to JP Morgan,...
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
07:44am, Tuesday, 06'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, scienc
LSEG, Rolls-Royce, AstraZeneca and Rightmove spotlighted as investment bank eyes potential winners for 2026
08:31am, Wednesday, 24'th Dec 2025
The festive period is, for some, a time for taking stock of what's happened in the past year - for others, though, its a time to pick stocks for the year ahead. So it is, then, that it's the season fo
ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?
11:56am, Tuesday, 23'rd Dec 2025
AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply diverge.
Here's Why Astrazeneca (AZN) is a Strong Value Stock
10:41am, Tuesday, 23'rd Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Big Drug Stocks That May Continue to Outperform in 2026
09:51am, Tuesday, 23'rd Dec 2025
Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised)
04:16am, Tuesday, 23'rd Dec 2025
AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.
AstraZeneca (LON:AZN) Insider Nazneen Rahman Sells 297 Shares of Stock
01:14am, Tuesday, 23'rd Dec 2025
AstraZeneca PLC (LON: AZN - Get Free Report) insider Nazneen Rahman sold 297 shares of the company's stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of �
